Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Antigenics Inc (AGEN)  
$0.44 0.00 (0.00%) as of 4:30 Thu 4/11


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 381,510,000
Market Cap: 169.20(M)
Last Volume: 4,513,016 Avg Vol: 4,500,422
52 Week Range: $0.4435 - $2.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Agenus is a clinical-stage immuno-oncology (I-O) company engaged in the development of a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer and infections. Co.'s antibody candidates are balstilimab (an anti-PD-1 antibody) and zalifrelimab (an anti-CTLA-4 antibody), which are in Phase 2 trials as both a monotherapy (balstilimab) and combination therapy (balstilimab/zalifrelimab) for treatment of patients with second-line cervical cancer. Co. is also developing an anti-CTLA-4 antibody, botensilimab (also known as AGEN1181), which is designed to improve the magnitude of responses to first-generation anti-CTLA-4 molecules.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 500,000 525,000 525,000 525,000
Total Buy Value $324,050 $343,050 $343,050 $343,050
Total People Bought 1 2 2 2
Total Buy Transactions 1 2 2 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 186
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baysal Ozer Chief Business Officer   •       –      –    2016-04-26 4/A D $4.15 $14,712 D/D (3,545) 33,633     -
   Baysal Ozer Chief Business Officer   •       –      –    2016-04-26 4/A A $4.15 $54,274 D/D 13,078 37,178     -
   Ballantyne Charles Evan Chief Financial Officer   •       –      –    2016-04-26 4 D $4.15 $29,195 D/D (7,035) 14,648     -
   Ballantyne Charles Evan Chief Financial Officer   •       –      –    2016-04-26 4 A $4.15 $89,984 D/D 21,683 21,683     -
   Baysal Ozer Chief Business Officer   •       –      –    2016-04-26 4 $4.15 $14,562 D/D 3,509 9,438     -
   Baysal Ozer Chief Business Officer   •       –      –    2016-04-26 4 A $4.15 $53,730 D/D 12,947 12,947     -
   Klaskin Christine M VP, Finance   •       –      –    2016-04-26 4 D $4.15 $14,596 D/D (3,517) 6,808     -
   Klaskin Christine M VP, Finance   •       –      –    2016-04-26 4 A $4.15 $42,849 D/D 10,325 10,325     -
   Armen Garo H Chief Executive Officer   •       –      –    2016-04-26 4 D $4.15 $109,755 D/D (26,447) 1,296,026     -
   Armen Garo H Chief Executive Officer   •       –      –    2016-04-26 4 A $4.15 $295,667 D/D 71,245 1,322,473     -
   Stein Robert Benjamin Chief Scientific Officer   •       –      –    2016-04-26 4 D $4.15 $50,900 D/D (12,265) 20,776     -
   Stein Robert Benjamin Chief Scientific Officer   •       –      –    2016-04-26 4 A $4.15 $137,120 D/D 33,041 33,041     -
   Valentine Karen Chief Legal Officer   •       –      –    2016-04-26 4 D $4.15 $33,146 D/D (7,987) 16,587     -
   Valentine Karen Chief Legal Officer   •       –      –    2016-04-26 4 A $4.15 $101,982 D/D 24,574 24,574     -
   Armen Garo H Chairman & CEO   •       –      –    2016-03-07 4 B $4.03 $805,600 D/D 200,000 1,251,228 2.74     -
   Baysal Ozer Chief Business Officer   •       –      –    2016-01-04 4 A $4.46 $27,875 D/D 6,250 21,850     -
   Armen Garo H Chairman & CEO   •       –      –    2015-12-30 4 D $4.63 $750,060 D/D (162,000) 1,051,228     -
   Armen Garo H Chairman & CEO   •       –      –    2015-12-29 4 S $4.57 $389,602 D/D (85,224) 1,213,228     -
   Armen Garo H Chairman & CEO   •       –      –    2015-12-28 4 S $4.59 $618,276 D/D (134,352) 1,298,452     -
   Armen Garo H Chairman & CEO   •       –      –    2015-10-02 4 D $4.82 $291,610 D/D (60,500) 1,432,804     -
   Armen Garo H Chairman & CEO   •       –      –    2015-10-01 4 A $6.61 $553,237 D/D 83,697 1,493,304     -
   Sharp Shalini Director   –       •      –    2015-09-28 4 A $4.59 $100,980 I/I 22,000 104,270     -
   Ballantyne Charles Evan Chief Financial Officer   •       –      –    2015-09-25 4 B $5.05 $50,500 D/D 10,000 10,000 2.74     -
   Armen Garo H Chairman & CEO   •       –      –    2015-09-25 4 B $5.03 $503,000 D/D 100,000 1,409,607 2.74     -
   Armen Garo H Chairman & CEO   •       –      –    2015-09-16 4 D $6.50 $393,250 D/D (60,500) 1,332,804     -
  186 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us